作者: Sui Tianqi , Zhang Tao , Lu Ning , Cheng Genhong , Xing Wen
DOI:
关键词:
摘要: The invention relates to use of serum markers containing alpha fetal protein (AFP), Golgi 73 (GP73) and carcinoembryonic antigen associated cell adhesion molecule 1 (CEACAM1) in diagnosis liver diseases. Specifically, the provides reagents an associative part at least one specific binding AFP, GP73 CECAM1 preparation kits for and/or prognosis